PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+32.21%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.4B
AUM Growth
+$2.4B
(+28%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
4.36%
Top 10 Holdings %
Top 10 Hldgs %
68.89%
Holding
38
New
2
Increased
14
Reduced
2
Closed
1
Top Buys
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$52.8M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$23M |
| 3 |
Vanda Pharmaceuticals
VNDA
|
$16.5M |
| 4 |
KLDO
Kaleido Biosciences, Inc. Common Stock
KLDO
|
$12.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$7.26M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$25.1M |
| 2 |
SHPG
Shire pic
SHPG
|
$8.34M |
| 3 |
MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
|
$144K |
Sector Composition
| 1 | Healthcare | 89.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BioMarin Pharmaceuticals
BMRN
$11.2B
| $235M | 9.79% | 2,641,485 +81,752 | +3% | +$7.26M |
|
2
Insmed
INSM
$28.8B
| $222M | 9.28% | 7,653,617 | – | – |
|
|
ABMD
3
DELISTED
Abiomed Inc
ABMD
| $200M | 8.32% | 698,654 +9,104 | +1% | +$2.6M |
|
4
United Therapeutics
UTHR
$13.8B
| $192M | 7.99% | 1,632,025 | – | – |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $166M | 6.93% | 1,229,030 +24,702 | +2% | +$3.34M |
|
6
STAAR Surgical
STAA
$1.36B
| $144M | 6.02% | 4,218,902 +70,914 | +2% | +$2.42M |
|
|
SAGE
7
DELISTED
Sage Therapeutics
SAGE
| $136M | 5.69% | 857,681 +6,704 | +0.8% | +$1.07M |
|
|
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
| $130M | 5.43% | 5,239,304 | – | – |
|
|
IMMU
9
DELISTED
Immunomedics Inc
IMMU
| $123M | 5.11% | 6,381,555 +1,195,300 | +23% | +$23M |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $104M | 4.32% | 7,619,833 +218,512 | +3% | +$2.97M |
|
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $93M | 3.88% | 5,055,050 +899,380 | +22% | +$16.5M |
|
|
WMGI
12
DELISTED
Wright Medical Group Inc
WMGI
| $87.2M | 3.64% | 2,771,394 | – | – |
|
|
EPZM
13
DELISTED
Epizyme, Inc
EPZM
| $85.9M | 3.58% | 6,935,074 | – | – |
|
|
AIMT
14
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $83.8M | 3.5% | 3,748,939 +2,361,350 | +170% | +$52.8M |
|
15
Acadia Pharmaceuticals
ACAD
$4.38B
| $60.4M | 2.52% | 2,248,403 +222,340 | +11% | +$5.97M |
|
16
Align Technology
ALGN
$10.3B
| $47M | 1.96% | 165,405 +8,582 | +5% | +$2.44M |
|
17
Puma Biotechnology
PBYI
$254M
| $45.8M | 1.91% | 1,180,780 +20,880 | +2% | +$810K |
|
|
AMAG
18
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $44.1M | 1.84% | 3,421,306 +40,800 | +1% | +$525K |
|
19
Karyopharm Therapeutics
KPTI
$61.7M
| $30.7M | 1.28% | 5,262,263 +576,911 | +12% | +$3.37M |
|
20
Exact Sciences
EXAS
$8.98B
| $27.3M | 1.14% | 314,889 | – | – |
|
|
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $26.8M | 1.12% | 1,841,613 | – | – |
|
|
ALDR
22
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $25.4M | 1.06% | 1,861,630 | – | – |
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $25.1M | 1.05% | 266,333 -266,334 | -50% | -$25.1M |
|
24
Prothena Corp
PRTA
$441M
| $13.4M | 0.56% | 1,108,510 | – | – |
|
|
KLDO
25
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $12.6M | 0.52% | +866,666 | New | +$12.6M |
|